Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
13.38
-1.07 (-7.40%)
At close: May 12, 2025, 4:00 PM
13.50
+0.12 (0.90%)
After-hours: May 12, 2025, 6:17 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $25.15 million as of May 12, 2025. Its market cap has increased by 266.73% in one year.
Market Cap
25.15M
Enterprise Value
19.83M
1-Year Change
266.73%
Ranking
Category
Stock Price
$13.38
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $25.15M, a decrease of -56.77%. That is a compound annual growth rate of -30.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 27.16M | 5.16% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |